Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -220,030 | -135,789 | -111,985 | -121,287 | -2,318 |
| Depreciation Amortization | 5,899 | 6,122 | 1,277 | 1,525 | 1,300 |
| Accounts receivable | -1,561 | 1,114 | 1,183 | -1,080 | -1,063 |
| Other Working Capital | 31,985 | -22,136 | 12,269 | -5,305 | 6,933 |
| Other Operating Activity | 34,242 | 22,150 | 32,561 | 96,453 | -28,531 |
| Operating Cash Flow | $-149,465 | $-128,539 | $-64,695 | $-29,694 | $-23,679 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,938 | -139,455 | 0 | 0 | N/A |
| PPE Investments | -3,401 | -25,444 | -2,370 | -108 | -1,178 |
| Purchase Of Investment | -10,695 | N/A | -7,897 | 0 | N/A |
| Sale Of Investment | 0 | 7,250 | 0 | 0 | N/A |
| Purchase Sale Intangibles | -1,432 | -1,381 | -1,405 | -1,037 | -1,127 |
| Other Investing Activity | -1,432 | -1,381 | -1,405 | -1,037 | -1,127 |
| Investing Cash Flow | $8,410 | $-159,030 | $-11,672 | $-1,145 | $-2,305 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 0 | 0 | N/A | N/A |
| Debt Repayment | -2,598 | -94 | -89 | -85 | -81 |
| Common Stock Issued | 130,805 | 104,249 | 145,986 | 178,681 | 32,380 |
| Other Financing Activity | -399 | 0 | -226 | 0 | 0 |
| Financing Cash Flow | $147,808 | $104,155 | $145,671 | $178,596 | $32,299 |
| Beginning Cash Position | 73,687 | 256,965 | 187,661 | 39,904 | 33,589 |
| End Cash Position | 80,440 | 73,551 | 256,965 | 187,661 | 39,904 |
| Net Cash Flow | $6,753 | $-183,414 | $69,304 | $147,757 | $6,315 |
| Free Cash Flow | |||||
| Operating Cash Flow | -149,465 | -128,539 | -64,695 | -29,694 | -23,679 |
| Capital Expenditure | -3,401 | -25,444 | -2,370 | -108 | -1,178 |
| Free Cash Flow | -152,866 | -153,983 | -67,065 | -29,802 | -24,857 |